News

Gladstone in the News June 27, 2020

Study Reveals Images of the Coronavirus Forming Tentacles in Cells—but Monstrous Discovery Helps Identify New Treatment

Milwaukee Journal Sentinel—Senior Investigator Nevan Krogan, PhD, explains his team's latest discovery that drugs belonging to a class known as kinase inhibitors can slow SARS-CoV-2 proliferation in cultured cells more efficiently than the antiviral Remdesivir.

Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab

Gladstone in the News June 27, 2020

A ‘Cure for Heart Disease’? A Single Shot Succeeds in Monkeys

The New York Times—Gladstone President Deepak Srivastava, MD, and Senior Investigator Jennifer Doudna, PhD, comment on a recent report of the successful use of novel CRISPR technology to lower cholesterol and triglyceride levels in monkeys.

Gladstone Experts Heart Failure Cardiovascular Disease Data Science and Biotechnology Doudna Lab Srivastava Lab CRISPR/Gene Editing Disease Models

Article June 24, 2020

Lung Organoids: Mini-Models for Mega Answers

Screening potential COVID-19 drug therapies through lung organoids promises a faster pipeline to approved treatments.

Gladstone Experts COVID-19 Infectious Disease Krogan Lab Ott Lab Organoids

Video June 19, 2020

Current and Future Strategies to Treat and Prevent Alzheimer’s Disease

With an estimated 44 million diagnosed with Alzheimer’s disease worldwide, research is moving quickly to better understand the disease.

Gladstone Experts Alzheimer’s Disease Neurological Disease Mahley Lab Mucke Lab

Gladstone in the News June 19, 2020

With Father’s Day and Summer BBQs Coming Up, Is There a Safe Way to Socialize?

San Francisco Chronicle—As nice weather and summer celebrations beckon, Senior Investigator Warner Greene comments on the need for people to socialize after months in lock-down, but warns against the dangers for large social gatherings to spread the coronavirus.

Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab

Gladstone in the News June 17, 2020

For the First Time, a Drug Is Found to Reduce Coronavirus Death Rate

San Francisco Chronicle—Gladstone Senior Investigators Melanie Ott and Warner Greene explain the potential risks and benefits of steroid treatments for COVID-19 patients.

Gladstone Experts COVID-19 Center for HIV Cure Research Infectious Disease Greene Lab Ott Lab

Gladstone in the News June 16, 2020

The Cheap Steroid Being Hailed as Life-saving COVID-19 Treatment: What We Know about Dexamethasone

San Francisco Chronicle—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, comments on the recent report that dexamethasone, a common anti-inflammatory drug, reduces the death rate of severely ill COVID-19 patients by one third.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Gladstone in the News June 10, 2020

Researchers Profile Immune Cells Implicated in Neurodegenerative Disease

ImmunoFrontiers—Senior Investigator Katerina Akassoglou, PhD, describes her lab's recent discovery of the genetic mechanisms that drive brain inflammation in neurodegenerative diseases.

Gladstone Experts Parkinson’s Disease Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab

Gladstone in the News June 2, 2020

Monster or Machine? A Profile of the Coronavirus at 6 Months

The New York Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, is one of the virologists prominently featured in this detailed account of the COVID-19 pandemic and of scientists’ efforts to understand and fight the coronavirus.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Video June 1, 2020

Exploring Human Microbes through Big Data

In this episode of the Newton Series, Katie Pollard shares how big data allows for deep exploration of the human microbiome.

Gladstone Experts Data Science and Biotechnology Pollard Lab Big Data Microbiome

Gladstone in the News May 31, 2020

Why Do Some People Refuse to Wear Masks? Defiance, Misguided Thinking

San Francisco Chronicle—Wearing a mask is increasingly mandated by businesses and local jurisdictions, but some people have refused to comply. Senior Investigator Warner Greene explains that since the coronavirus is spread by respiratory droplets, a mask is an extremely effective way to reduce transmission.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Gladstone in the News May 29, 2020

How Accurate Are Antibody Tests?

Deep Background with Noah Feldman—Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, shares the results of his lab's evaluation of currently available antibody tests for SARS-CoV-2 infection.

Gladstone Experts COVID-19 Genomic Immunology Marson Lab

Gladstone in the News May 29, 2020

Inspire Awards: Melanie Ott Leads Research into Biology of COVID-19

SF Business Times—Melanie Ott, director of the Gladstone Institute of Virology, was recently named one of the most influential women in Bay Area business by the San Francisco Business Times. She reflects on the similarities between the AIDS crisis and the current COVID-19 pandemic, and describes how her lab has refocused their efforts on the novel virus.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Gladstone in the News May 29, 2020

Inspire Awards: Jennifer Doudna Transforms UC Berkeley Lab to Process COVID-19 Tests

San Francisco Business Times—Early on in the pandemic, Gladstone Senior Investigator Jennifer Doudna, PhD, co-discoverer of CRISPR, recognized the need for safe, reliable, and rapid COVID-19 testing. She quickly mobilized a team of scientists from UC Berkeley, UC San Francisco, and elsewhere to develop a high-throughput detection assay and test vulnerable and at-risk populations in the Bay Area. Doudna was recently named one of the most influential women in Bay Area business by the San Francisco Business Times.

Womens Initiative Gladstone Experts COVID-19 Data Science and Biotechnology Doudna Lab

Video May 28, 2020

Finding Our Way Out: Gladstone’s COVID-19 Research

Get a deeper look at the most promising COVID-19 projects at Gladstone.

Gladstone Experts COVID-19